CALMARE THERAPEUTICS Inc: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2016)

$1.1M

Net Income/Loss (FY2016)

-$3.8M

Total Assets (FY2016)

$3.9M

Total Equity (FY2016)

-$13.8M

Cash Flows from Operating Activities (FY2016)

-$1.2M

Source: CALMARE THERAPEUTICS Inc 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.